rs763862849
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_052859.4(RFT1):c.454A>G(p.Lys152Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000266 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_052859.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFT1 | ENST00000296292.8 | c.454A>G | p.Lys152Glu | missense_variant, splice_region_variant | Exon 4 of 13 | 1 | NM_052859.4 | ENSP00000296292.3 | ||
RFT1 | ENST00000394738.7 | c.337A>G | p.Lys113Glu | missense_variant, splice_region_variant | Exon 3 of 12 | 5 | ENSP00000378223.3 | |||
RFT1 | ENST00000467048.1 | c.454A>G | p.Lys152Glu | missense_variant, splice_region_variant | Exon 4 of 9 | 3 | ENSP00000420325.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251342Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135842
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461624Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727116
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74334
ClinVar
Submissions by phenotype
RFT1-congenital disorder of glycosylation Pathogenic:3
- -
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 152 of the RFT1 protein (p.Lys152Glu). This variant is present in population databases (rs763862849, gnomAD 0.009%). This missense change has been observed in individual(s) with clinical features of RFT1-related conditions (PMID: 19701946, 19856127, 26892341, 27172925). ClinVar contains an entry for this variant (Variation ID: 207986). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
not provided Pathogenic:1
DNA sequence analysis of the RFT1 gene demonstrated a sequence change, c.454A>G, in exon 4 that results in an amino acid change, p.Lys152Glu. This sequence change has been previously described in two patients in the homozygous state with neurological and clinical features of RFT1-related disorder (PMIDs: 19856127, 19701946). Expression of wild-type RFT1 in the patients? fibroblasts showed complementation of the abnormal lipid-linked oligosaccharide profile and reduced DNase 1 secretion, supporting RFT1 defect (PMID: 19701946). This sequence change has been described in the gnomAD database with a low population frequency of 0.0052% (dbSNP rs763862849). The p.Lys152Glu change affects a highly conserved amino acid residue located in a domain of the RFT1 protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Lys152Glu substitution. These collective evidences indicate that this sequence change is pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at